The pharmacogGENEtics in Youth Depression (GENE-YD) study for personalizing antidepressant pharmacotherapy for young Western Australians - A feasibility study.

Bradley Roberts; Zahra Cooper; Aleksandra Miljevic; Susanne Stanley; Bernadette T Majda; Khan R L Collins; Sarah Woodland; Michael J Kyron; Svetlana Baltic; Suzanna E L Temple; P Anthony Akkari; Sean D Hood; Jennifer Rodger

doi:10.1038/s41398-026-04321-x

SCHEDA SCIENTIFICA2026Studio randomizzato

The pharmacogGENEtics in Youth Depression (GENE-YD) study for personalizing antidepressant pharmacotherapy for young Western Australians - A feasibility study.

Bradley Roberts, Zahra Cooper, Aleksandra Miljevic, Susanne Stanley, Bernadette T Majda, Khan R L Collins, Sarah Woodland, Michael J Kyron, Svetlana Baltic, Suzanna E L Temple, P Anthony Akkari, Sean D Hood, Jennifer Rodger

Translational psychiatry · 2026

Psicologia clinica Psicoterapia Psicopatologia Psicodiagnostica

Abstract e pubblicazione originale

L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.

Leggi nella fonte originale ↗

Parole chiave

HumansFemaleAdolescentFeasibility StudiesMaleYoung AdultMajor Depressive DisorderAntidepressive AgentsPilot ProjectsPrecision MedicineQuality of LifeAustraliaPharmacogenomic TestingPharmacogeneticsTreatment OutcomeAustralasian People

Come citare questo studio

Bradley Roberts, Zahra Cooper, Aleksandra Miljevic, Susanne Stanley, Bernadette T Majda, Khan R L Collins, Sarah Woodland, Michael J Kyron, Svetlana Baltic, Suzanna E L Temple, P Anthony Akkari, Sean D Hood, Jennifer Rodger. (2026). The pharmacogGENEtics in Youth Depression (GENE-YD) study for personalizing antidepressant pharmacotherapy for young Western Australians - A feasibility study.. Translational psychiatry. DOI: 10.1038/s41398-026-04321-x

Consulta la pubblicazione originale ↗